Juncture Wealth Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
1,228
-6
-0.5% -$1.4K 0.08% 146
2026
Q1
$302K Sell
1,234
-75
-6% -$17.5K 0.1% 109
2025
Q4
$271K Sell
1,309
-137
-9% -$27.1K 0.09% 113
2025
Q3
$268K Buy
1,446
+131
+10% +$22.4K 0.09% 110
2025
Q2
$201K Buy
+1,315
New +$202K 0.07% 119
2023
Q1
Sell
-1,383
Closed -$244K 111
2022
Q4
$244K Buy
+1,383
New +$239K 0.12% 100
2015
Q1
Sell
-2,100
Closed -$220K 77
2014
Q4
$220K Buy
+2,100
New +$221K 0.11% 70

Other funds holding JNJ

Juncture Wealth Strategies's JNJ Position: Q2 2026 in Review

Juncture Wealth Strategies reduced its Johnson & Johnson (JNJ) stake by 0.49% in Q2 2026, selling an estimated $1.4K and leaving 1,228 shares worth $312K. The position accounts for 0.08% of the portfolio, ranked #146.

Juncture Wealth Strategies first reported a position in JNJ in Q4 2014 and has held it in 7 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Juncture Wealth Strategies held 1,228 shares of Johnson & Johnson worth $312K as of Q2 2026.
  • Juncture Wealth Strategies sold 6 Johnson & Johnson shares in Q2 2026, an estimated $1.4K.
  • Johnson & Johnson made up 0.08% of Juncture Wealth Strategies's portfolio in Q2 2026, its #146 holding.
  • Juncture Wealth Strategies first reported a position in Johnson & Johnson in Q4 2014 and has held it in 7 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.